Phenotypic spectrum of mutations in DAX-1 and SF-1
The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
SF-1 (steroidogenic factor-1) (NR5A1) and DAX-1 (dosage-sensitive sex-reversal, adrenal hypoplasia congenital, X chromosome) (NR0B1) are orphan nuclear receptors that are expressed in the adrenal gland, gonads, ventromedial hypothalamus (VMH), and pituitary gonadotrope cells. The function of these genes has been clarified by examining the consequences of naturally occurring mutations in humans, as well as targeted disruption of the genes in mice. Mutations in DAX1 cause adrenal hypoplasia congenita (AHC), an X-linked disorder characterized by adrenal insufficiency and failure to undergo puberty because of hypogonadotropic hypogonadism. Most DAX1 mutations introduce frameshifts and/or cause premature termination of the protein. Relatively few missense mutations have been described and all are located within the carboxy-terminal half of the protein. Transfection assays demonstrate that AHC-associated DAX1 mutations abrogate its ability to act as a transcriptional repressor of SF-1. Most boys affected with AHC present with adrenal insufficiency in early infancy, although a significant fraction present in later childhood or even as young adults. The degree of gonadotropin deficiency is also variable. With the exception of one mild missense DAX1 mutation, genotype-phenotype correlations have been elusive, suggesting an important role for modifier genes. Targeted mutagenesis of Dax1 (Ahch) in mice reveals an additional role in testis development and spermatogenesis. Similar abnormalities appear to be present in humans. Targeted mutagenesis of Sf1 (FtzF1) prevents gonadal and adrenal development, and causes male-to-female sex-reversal. A human XY individual with a heterozygous SF1 mutation presented with adrenal insufficiency and complete sex-reversal; this DNA-binding domain mutation prevents SF-1 stimulation of its target genes. In addition to their clinical relevance, studies of SF1 and DAX1 are proving useful for unraveling the genetic pathways that govern adrenal and gonadal development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SF1 mutations can result in adrenal insufficiency (Achermann et al., 2001).”
From Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells (2018) · cites this paper as Achermann et al., 2001
Citations
Cites
WT-1 is required for early kidney development
Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., & Jaenisch, R. (1993) · Cell · doi:10.1016/0092-8674(93)90515-r · Cited by 1,989
Luo, X., Ikeda, Y., & Parker, K. L. (1994) · Cell · doi:10.1016/0092-8674(94)90211-9 · Cited by 1,631
Determinants of target gene specificity for steroid/thyroid hormone receptors
Umesono, K., & Evans, R. M. (1989) · Cell · doi:10.1016/0092-8674(89)90051-2 · Cited by 948
Zanaria, E., Muscatelli, F., Bardoni, B., Strom, T. M., Guioli, S., Guo, W., Lalli, E., Moser, C., Walker, A. P., McCabe, E. R. B., et al. (1994) · Nature · doi:10.1038/372635a0 · Cited by 858
Muscatelli, F., Strom, T. M., Walker, A. P., Zanaria, E., Récan, D., Meindl, A., Bardoni, B., Guioli, S., Zehetner, G., Rabl, W., et al. (1994) · Nature · doi:10.1038/372672a0 · Cited by 767
Achermann, J. C., Ito, M., Ito, M., Hindmarsh, P. C., & Jameson, J. L. (1999) · Nature Genetics · doi:10.1038/9629 · Cited by 709
Self-citationLala, D. S. (1992) · Molecular Endocrinology · doi:10.1210/me.6.8.1249 · Cited by 678
A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal
Bardoni, B., Zanaria, E., Guioli, S., Floridia, G., Worley, K. C., Tonini, G., Ferrante, E., Chiumello, G., McCabe, E. R. B., Fraccaro, M., et al. (1994) · Nature Genetics · doi:10.1038/ng0894-497 · Cited by 610
The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis.
Ingraham, H. A., Lala, D. S., Ikeda, Y., Luo, X., Shen, W. H., Nachtigal, M. W., Abbud, R., Nilson, J. H., & Parker, K. L. (1994) · Genes & Development · doi:10.1101/gad.8.19.2302 · Cited by 602
Shen, W.-H., Moore, C. C. D., Ikeda, Y., Parker, K. L., & Ingraham, H. A. (1994) · Cell · doi:10.1016/0092-8674(94)90050-7 · Cited by 559
Cited by
A Window of Opportunity: The Diagnosis of Gonadotropin Deficiency in the Male Infant1
Grumbach, M. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2465 · Cited by 286
SF-1 a key player in the development and differentiation of steroidogenic tissues
Val, P., Lefrançois-Martinez, A.-M., Veyssière, G., & Martinez, A. (2003) · Nuclear Receptor · doi:10.1186/1478-1336-1-8 · Cited by 257
Development of adrenal cortex zonation
Xing, Y., Lerario, A. M., Rainey, W., & Hammer, G. D. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.001 · Cited by 174
“In the adrenal, Dax1 primarily serves as a corepressor of Sf1mediated transcription of steroidogenic genes.(4,19,29) Consistent with this role and”
Molecular aspects of steroidogenic factor 1 (SF-1)
Hoivik, E. A., Lewis, A. E., Aumo, L., & Bakke, M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.003 · Cited by 168
Structural Basis for Ligand-Independent Activation of the Orphan Nuclear Receptor LRH-1
Sablin, E. P., Krylova, I. N., Fletterick, R. J., & Ingraham, H. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00236-3 · Cited by 164
Metadata
- Authors
- Achermann, J. C., Meeks, J. J., & Larry Jameson, J.
- Affiliations
- Northwestern University (US)
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2001-12
- Volume
- 185
- Issue
- 1-2
- Pages
- 17-25
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W2017986226
- Cited by
- 163
- References
- 73
- Citations by year
- 2025: 5 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 9 · 2017: 6 · 2016: 8 · 2015: 9 · 2014: 5 · 2013: 8 · 2012: 5
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Molecular and Cellular Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- National Institutes of Health
- National Center for Research Resources (M01RR000048)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01HD021921, U54HD029164)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Keywords
- DAX-1, SF-1, NR0B1, steroidogenic factor 1, orphan nuclear receptor, congenital adrenal hypoplasia, hypogonadotropic hypogonadism, sex reversal, genotype-phenotype correlation, frameshift mutation, missense mutations, transcriptional repression, spermatogenesis, testicular development, adrenal development, gonad development, genetic modifiers
- MeSH terms
- Adrenal Glands, Animals, DNA-Binding Proteins, Female, Humans, Male, Mutation, Phenotype, Repressor Proteins, Testis, Transcription Factors, Genetic Variation, Mutagenesis, Site-Directed, Receptors, Cytoplasmic and Nuclear, Receptors, Retinoic Acid, Homeodomain Proteins, Fushi Tarazu Transcription Factors, Steroidogenic Factor 1, DAX-1 Orphan Nuclear Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phenotypic spectrum of mutations in DAX-1 and SF-1. https://app.cochat.ai/papers/10.1016/s0303-7207(01)00619-0
- The paper
- Achermann, J. C., Meeks, J. J., & Larry Jameson, J. (2001). Phenotypic spectrum of mutations in DAX-1 and SF-1. Molecular and Cellular Endocrinology. https://doi.org/10.1016/s0303-7207(01)00619-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.